Page last updated: 2024-10-18

glycine and Cancer of Prostate

glycine has been researched along with Cancer of Prostate in 27 studies

Research Excerpts

ExcerptRelevanceReference
"Plasma acylcarnitines [(C2, C16:1, C18, C18:1, C18:1-OH, and C18:2)], glycerophospholipids (lysophosphatidylcholine-acyl, -di-acyl, and -di-acyl acyl-alkyl) and sphingomyelins [SM (OH) C16:1, SM C18:0, SM C18:1, and SM C20:2] significantly increased on PND 145, when chronic inflammation was observed in the dorsolateral prostate of rats dosed with EB, T, and E."3.96Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones. ( Beger, RD; Cao, Z; Nakamura, N; Pence, LM, 2020)
"Eight patients with biopsy-proven prostate cancer who were scheduled for either radical prostatectomy or external beam radiotherapy underwent (99m)Tc-HABBN scintigraphy and SPECT/CT prior to treatment."2.78Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study. ( Ananias, HJ; Chen, X; de Jong, IJ; Dierckx, RA; Elsinga, PH; Helfrich, W; Hoving, HD; Lub-de Hooge, MN; Pruim, J; Rosati, S; Wang, F; Yan, Y; Yu, Z, 2013)
"Mannitol and sorbitol were determined in plasma and urine; glycine and ethanol were determined in plasma."2.67A comparison between two hypotonic irrigating solutions used in transurethral resections of the prostate: sorbitol (2%)-mannitol (1%) and 1.5% glycine solutions. ( Allgén, LG; Allgén, T; Dimberg, M; Norlén, H; Wallin, M, 1992)
"The Arg388 allele increased prostate cancer risk compared with Gly388 allele (OR = 1."2.47FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls. ( Chen, M; Chen, SQ; Hua, LX; Tong, N; Wang, ZJ; Xu, B; Zhang, ZD, 2011)
"The androgen-directed treatment of prostate cancer (PCa) is fraught with the recurrent profile of failed treatment due to drug resistance and must be addressed if we are to provide an effective therapeutic option."1.51A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy. ( Beitel, LK; Chowdhury, S; Lumbroso, R; Paliouras, M; Purisima, EO; Trifiro, M, 2019)
"ON 01910."1.35Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent. ( Chun, AW; Cosenza, SC; Maniar, M; Taft, DR, 2009)

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19903 (11.11)18.7374
1990's3 (11.11)18.2507
2000's6 (22.22)29.6817
2010's13 (48.15)24.3611
2020's2 (7.41)2.80

Authors

AuthorsStudies
Nakamura, N1
Pence, LM1
Cao, Z1
Beger, RD1
Zagefka, H1
Huynh, HP1
Senger, AR1
Derington, CG1
Colantonio, LD1
Herrick, JS1
Cook, J1
King, JB1
Rosenson, RS1
Poudel, B1
Monda, KL1
Navar, AM1
Mues, KE1
Stevens, VW1
Nelson, RE1
Vanneman, ME1
Muntner, P1
Bress, AP1
Ma, B1
Ren, G1
Xu, J2
Yin, C2
Shi, Y1
Rahsepar, AA1
Bluemke, DA1
Habibi, M1
Liu, K1
Kawel-Boehm, N1
Ambale-Venkatesh, B1
Fernandes, VRS1
Rosen, BD1
Lima, JAC1
Carr, JC1
Freitag, TM1
Chen-Sankey, JC1
Duarte, DA1
Ramsey, MW1
Choi, K1
Winkler-Heil, R1
Hussain, M1
Hofmann, W1
Nicotera, AG1
Dicanio, D1
Pironti, E1
Bonsignore, M1
Cafeo, A1
Efthymiou, S1
Mondello, P1
Salpietro, V1
Houlden, H1
Di Rosa, G1
Hayes-Ryan, D1
O'Donoghue, K1
McCarthy, C1
Totorika, A1
Meaney, S1
Pang, RD1
Dormanesh, A1
Hoang, Y1
Chu, M1
Allem, JP1
Girón-Ortega, JA1
Márquez-Coello, M1
Gutiérrez-Saborido, D1
Arizcorreta, A1
Cuesta-Sancho, S1
Girón-González, JA1
Dovrat, G1
Pevzner, S1
Berthon, C1
Lerner, A1
Maimon, E1
Vainer, R1
Karpasas, M1
Ben-Elyiahu, Y1
Moisy, P1
Bettelheim, A1
Zilbermann, I1
Vanden Broeck, SMP1
Nelson, DJ1
Collado, A1
Falivene, L1
Cavallo, L1
Cordes, DB1
Slawin, AMZ1
Van Hecke, K1
Nahra, F1
Cazin, CSJ1
Nolan, SP1
Kranidiotis-Hisatomi, N1
Yi, H1
Oestreich, M1
Kwiezinski, C1
Weller, C1
van Pinxteren, D1
Brüggemann, M1
Mertes, S1
Stratmann, F1
Herrmann, H1
Treggiari, D1
Tridello, G1
Menin, L1
Borruso, A1
Pintani, E1
Iansa, P1
Cipolli, M1
Melotti, P1
Ren, L1
Liu, L3
Shu, X1
Lin, W1
Yang, P1
Chen, J1
Teo, KL1
Xiao, F1
Wang, H1
Yao, T1
Zhao, X1
Yang, X1
Yu, DYW1
Rogach, AL1
Bordet, A1
Leitner, W1
Gao, S1
Xia, F1
Li, B2
Abdul Razak, IB1
Liu, Y1
Lu, K1
Brown, DE1
Wang, R1
Cheng, Y1
Ni, S1
Qu, H1
Xing, H1
Xu, Z1
Zhu, X1
Yuan, M1
Wang, L1
Yu, J1
Li, Y1
Yang, L1
Liu, H1
Cao, L1
Zhang, S1
Zhao, D1
Yan, T1
Yang, G1
Lin, Z1
Luo, M1
Ye, N1
Lee, SW1
Carnicelli, J1
Getya, D1
Gitsov, I1
Phillips, KS1
Ren, D1
Grützmacher, PG1
Suarez, S1
Tolosa, A1
Gachot, C1
Song, G1
Wang, B1
Presser, V1
Mücklich, F1
Anasori, B1
Rosenkranz, A1
Demireva, M1
Armentrout, PB1
Feng, D1
Cao, K1
He, ZZ1
Knibbs, LD1
Jalaludin, B1
Leskinen, A1
Roponen, M1
Komppula, M1
Jalava, P1
Guo, PY1
Xu, SL1
Yang, BY1
Hu, L1
Zeng, XW1
Chen, G1
Yu, HY1
Lin, L1
Dong, G1
Machulkin, AE1
Shafikov, RR1
Uspenskaya, AA1
Petrov, SA1
Ber, AP1
Skvortsov, DA1
Nimenko, EA1
Zyk, NU1
Smirnova, GB1
Pokrovsky, VS1
Abakumov, MA1
Saltykova, IV1
Akhmirov, RT1
Garanina, AS1
Polshakov, VI1
Saveliev, OY1
Ivanenkov, YA1
Aladinskaya, AV1
Finko, AV1
Yamansarov, EU1
Krasnovskaya, OO1
Erofeev, AS1
Gorelkin, PV1
Dontsova, OA1
Beloglazkina, EK1
Zyk, NV1
Khazanova, ES1
Majouga, AG1
Zheng, YK1
Su, BJ1
Wang, YQ1
Wang, HS1
Liao, HB1
Liang, D1
Shataer, D1
Li, J1
Duan, XM1
Xin, XL1
Aisa, HA1
Allu, SR1
Ravotto, L1
Troxler, T1
Vinogradov, SA1
Cheruku, RR1
Tracy, EC1
Tabaczynski, W1
Missert, JR1
Baumann, H1
Pandey, RK1
Rohde, JM1
Karavadhi, S1
Pragani, R1
Fang, Y1
Zhang, W1
McIver, A1
Zheng, H1
Liu, Q1
Davis, MI1
Urban, DJ1
Lee, TD1
Cheff, DM1
Hollingshead, M1
Henderson, MJ1
Martinez, NJ1
Brimacombe, KR1
Yasgar, A1
Zhao, W1
Klumpp-Thomas, C1
Michael, S1
Covey, J1
Moore, WJ1
Stott, GM1
Li, Z1
Simeonov, A1
Jadhav, A1
Frye, S1
Hall, MD1
Shen, M1
Wang, X2
Patnaik, S1
Boxer, MB1
Zhang, H2
Cheng, C1
Huang, B1
Chen, R1
Huang, Y1
Chen, H1
Pei, W1
Katahara, S1
Sugiyama, Y1
Yamane, M1
Komiya, Y1
Sato, T1
Chida, N1
Chen, Y1
Filipov, NM1
Guo, TL1
Chowdhury, S1
Beitel, LK1
Lumbroso, R1
Purisima, EO1
Paliouras, M1
Trifiro, M1
de Vogel, S1
Ulvik, A1
Meyer, K1
Ueland, PM1
Nygård, O1
Vollset, SE1
Tell, GS1
Gregory, JF1
Tretli, S1
Bjørge, T1
Ananias, HJ1
Yu, Z1
Hoving, HD1
Rosati, S1
Dierckx, RA1
Wang, F1
Yan, Y1
Chen, X1
Pruim, J1
Lub-de Hooge, MN1
Helfrich, W1
Elsinga, PH1
de Jong, IJ1
van Rij, CM1
Frielink, C1
Goldenberg, DM1
Sharkey, RM1
Franssen, GM1
Lütje, S1
McBride, WJ1
Oyen, WJ1
Boerman, OC1
Panagiotou, OA1
Travis, RC1
Campa, D1
Berndt, SI1
Lindstrom, S1
Kraft, P1
Schumacher, FR1
Siddiq, A1
Papatheodorou, SI1
Stanford, JL1
Albanes, D1
Virtamo, J1
Weinstein, SJ1
Diver, WR1
Gapstur, SM1
Stevens, VL1
Boeing, H1
Bueno-de-Mesquita, HB1
Barricarte Gurrea, A1
Kaaks, R1
Khaw, KT1
Krogh, V1
Overvad, K1
Riboli, E1
Trichopoulos, D1
Giovannucci, E1
Stampfer, M1
Haiman, C1
Henderson, B1
Le Marchand, L1
Gaziano, JM1
Hunter, DJ1
Koutros, S1
Yeager, M1
Hoover, RN1
Chanock, SJ1
Wacholder, S1
Key, TJ1
Tsilidis, KK1
Cox, A1
Kumar, D1
Gupta, A1
Mandhani, A1
Sankhwar, SN1
Chun, AW1
Cosenza, SC1
Taft, DR1
Maniar, M1
Valero, M1
Morenilla-Palao, C1
Belmonte, C1
Viana, F1
Xu, B1
Tong, N1
Chen, SQ1
Hua, LX1
Wang, ZJ1
Zhang, ZD1
Chen, M1
Lamoureux, F1
Thomas, C1
Yin, MJ1
Kuruma, H1
Beraldi, E1
Fazli, L1
Zoubeidi, A1
Gleave, ME1
Lin, X1
Qu, L1
Chen, Z2
Xu, C1
Ye, D1
Shao, Q1
Qi, J1
Zhou, F1
Wang, M1
Wang, Z1
He, D1
Wu, D1
Gao, X1
Yuan, J1
Wang, G2
Xu, Y1
Dong, P1
Jiao, Y1
Yang, J1
Ou-Yang, J1
Jiang, H1
Zhu, Y1
Ren, S1
Zhang, Z1
Wu, Q1
Zheng, Y1
Turner, AR1
Tao, S1
Na, R1
Ding, Q1
Lu, D1
Shi, R1
Sun, J1
Liu, F1
Zheng, SL1
Mo, Z1
Sun, Y1
Madarame, J1
Higashiyama, S1
Kiyota, H1
Madachi, A1
Toki, F1
Shimomura, T1
Tani, N1
Oishi, Y1
Matsuura, N1
Ding, D1
Xu, L1
Menon, M1
Reddy, GP1
Barrack, ER1
Wang, J1
Stockton, DW1
Ittmann, M1
Minchenko, O1
Opentanova, I1
Minchenko, D1
Ogura, T1
Esumi, H1
Reagan-Shaw, S1
Ahmad, N1
Heinz, A1
Meyer, WW1
Hallwachs, O1
Widran, J1
Ts'ao, C1
Molteni, A1
Taylor, JM1
Dimberg, M1
Norlén, H1
Allgén, LG1
Allgén, T1
Wallin, M1
Schaefer, M1
Brühl, P1
Liappis, N1
Sugiura, H1
Shimaya, M1

Reviews

3 reviews available for glycine and Cancer of Prostate

ArticleYear
A genome-wide pleiotropy scan for prostate cancer risk.
    European urology, 2015, Volume: 67, Issue:4

    Topics: Disease Progression; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Gly

2015
FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
    BMC cancer, 2011, Feb-24, Volume: 11

    Topics: Amino Acid Substitution; Arginine; Biomarkers, Tumor; Carcinoma; Case-Control Studies; Cell Transfor

2011
Polo-like kinase (Plk) 1 as a target for prostate cancer management.
    IUBMB life, 2005, Volume: 57, Issue:10

    Topics: Animals; Antibodies; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformati

2005

Trials

4 trials available for glycine and Cancer of Prostate

ArticleYear
Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:7

    Topics: Aged; Aminocaproic Acid; Drug Stability; Feasibility Studies; Glycine; Humans; Male; Middle Aged; Mu

2013
A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
    The Prostate, 2013, Volume: 73, Issue:2

    Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Asian People; China; Genetic Predisposition to Dis

2013
[Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
    Der Urologe. Ausg. A, 1984, Volume: 23, Issue:3

    Topics: Aged; Anticoagulants; Antineoplastic Agents; Aspirin; Clinical Trials as Topic; Diethylstilbestrol;

1984
A comparison between two hypotonic irrigating solutions used in transurethral resections of the prostate: sorbitol (2%)-mannitol (1%) and 1.5% glycine solutions.
    Scandinavian journal of urology and nephrology, 1992, Volume: 26, Issue:3

    Topics: Aged; Blood Loss, Surgical; Creatinine; Ethanol; Glycine; Humans; Hypotonic Solutions; Male; Mannito

1992

Other Studies

20 other studies available for glycine and Cancer of Prostate

ArticleYear
Distinct lipid signatures are identified in the plasma of rats with chronic inflammation induced by estradiol benzoate and sex hormones.
    Metabolomics : Official journal of the Metabolomic Society, 2020, 09-07, Volume: 16, Issue:9

    Topics: Amino Acids; Animals; Biomarkers; Carnitine; Estradiol; Glycerophospholipids; Glycine; Gonadal Stero

2020
    Journal of applied social psychology, 2021, Volume: 51, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-

2021
Dietary Glycation Products Regulate Immune Homeostasis: Early Glycation Products Promote Prostate Cancer Cell Proliferation through Modulating Macrophages.
    Molecular nutrition & food research, 2018, Volume: 62, Issue:3

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cytokines; Female; Glucose; Glycation End Products, A

2018
A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy.
    Hormones & cancer, 2019, Volume: 10, Issue:1

    Topics: Amino Acid Motifs; Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Membrane; Chl

2019
Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
    International journal of cancer, 2014, Jan-01, Volume: 134, Issue:1

    Topics: Betaine; Biomarkers, Tumor; Case-Control Studies; Choline; Chromatography, Liquid; Cohort Studies; G

2014
Pretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenografts.
    Molecular imaging and biology, 2015, Volume: 17, Issue:1

    Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules

2015
Pleiotropy in aggressive prostate cancer?
    European urology, 2015, Volume: 67, Issue:4

    Topics: Genome-Wide Association Study; Glycine; Humans; Male; Polymorphism, Single Nucleotide; Prostatic Neo

2015
[In Process Citation].
    Aktuelle Urologie, 2015, Volume: 46, Issue:6

    Topics: Alanine; Amino Acid Substitution; Cell Transformation, Neoplastic; DNA Mutational Analysis; Glycine;

2015
NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
    The Prostate, 2016, Volume: 76, Issue:12

    Topics: Aged; Biomarkers, Tumor; Biopsy; Citric Acid; Diagnosis, Differential; Digital Rectal Examination; G

2016
Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
    Cancer chemotherapy and pharmacology, 2009, Volume: 65, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dogs; Dose-Response Relationship, Drug; Drug Evalu

2009
Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.
    Pflugers Archiv : European journal of physiology, 2011, Volume: 461, Issue:1

    Topics: Arginine; Calcium; Cell Line; Cell Line, Tumor; Cell Membrane; Clotrimazole; Cold Temperature; Endop

2011
Clusterin inhibition using OGX-011 synergistically enhances Hsp90 inhibitor activity by suppressing the heat shock response in castrate-resistant prostate cancer.
    Cancer research, 2011, Sep-01, Volume: 71, Issue:17

    Topics: Animals; Apoptosis; Benzamides; Benzoquinones; Cell Line, Tumor; Clusterin; Drug Synergism; Glycine;

2011
Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    The Prostate, 2003, Nov-01, Volume: 57, Issue:3

    Topics: Bombesin; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptor

2003
Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action.
    The Prostate, 2005, Feb-01, Volume: 62, Issue:2

    Topics: Androgens; Cell Line, Tumor; Glycine; Humans; Luciferases, Firefly; Male; Nucleic Acid Conformation;

2005
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 1

    Topics: Alleles; Arginine; Case-Control Studies; Cell Movement; Collagen; Disease Progression; DNA; DNA, Com

2004
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
    FEBS letters, 2004, Oct-08, Volume: 576, Issue:1-2

    Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cobalt; Deferoxamine; Enzyme Induction; E

2004
Controlled continuous flow method for transurethral resections.
    Urology, 1983, Volume: 21, Issue:2

    Topics: Aged; Blood Pressure; Computers; Glycine; Humans; Male; Middle Aged; Prostatectomy; Prostatic Diseas

1983
Injury-specific cytotoxic response of tumor cells and endothelial cells.
    Pathology, research and practice, 1996, Volume: 192, Issue:1

    Topics: Animals; Cattle; Cells, Cultured; Chromium Radioisotopes; Endopeptidases; Endothelium, Vascular; Gly

1996
[Low pressure trocar resection versus Iglesias suction resection].
    Der Urologe. Ausg. A, 1990, Volume: 29, Issue:4

    Topics: Glycine; Humans; Male; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Sodium; Suction; T

1990
[Clinical application of "PPC" to prostatic hypertrophy and others].
    Hinyokika kiyo. Acta urologica Japonica, 1969, Volume: 15, Issue:6

    Topics: Alanine; Capsules; Glutamates; Glycine; Humans; Male; Prostatic Diseases; Prostatic Hyperplasia; Pro

1969